Literature DB >> 14679335

Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C.

Bruno C Medeiros, Paul A Seligman, Gregory T Everson, Lisa M Forman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14679335     DOI: 10.1097/00004836-200401000-00019

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  5 in total

1.  Interferon-alpha induced severe thrombocytopenia: a case report and review of the literature.

Authors:  Li Li; Da-Kang Han; Jun Lu
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

2.  Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature.

Authors:  Rosario Arena; Paolo Cecinato; Andrea Lisotti; Federica Buonfiglioli; Claudio Calvanese; Giuseppe Grande; Marco Montagnani; Francesco Azzaroli; Giuseppe Mazzella
Journal:  World J Hepatol       Date:  2015-06-28

3.  Monoclonal antibody Rituximab for severe immune thrombocytopenia after pegylated interferon for hepatitis C infection.

Authors:  I Papakonstantinou; I Poulakidas
Journal:  Hippokratia       Date:  2014 Oct-Dec       Impact factor: 0.471

Review 4.  Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.

Authors:  Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

5.  The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report.

Authors:  Rita Lebano; Valerio Rosato; Mario Masarone; Marco Romano; Marcello Persico
Journal:  BMC Res Notes       Date:  2014-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.